^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JRF104

    i
    Other names: JRF104

    Associations

    News
    Trials
    Company:
    Jinrui Foundation, WuXi AppTec
    Drug class:
    FLT3 inhibitor, AXL inhibitor
    Related drugs:

    Associations

    News
    Trials